Northway Biotech
24.5.2023 18:24:40 CEST | ACCESS Newswire | Press release
WALTHAM, MA / ACCESSWIRE / May 24, 2023 / Northway Biotech, a biopharmaceutical contract development and manufacturing organization (CDMO), established in 2004, with an EMA and FDA-compliant, state-of-the-art cGMP manufacturing site in Vilnius, Lithuania, announced the completion of its expansion project for cGMP manufacturing facilities in Waltham, Massachusetts. This significant accomplishment further solidifies Northway Biotech's standing as an influential player in the global biopharmaceutical landscape.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.This recent growth is an extension of the successful launch of Northway Biotech's process and analytical development laboratories in Waltham (Greater Boston area) in 2020. The expanded facility now includes state-of-the-art cGMP suites, marking a significant milestone in the company's journey. The newly established cutting-edge biomanufacturing suites host a microbial fermentation train with up to 450 liters of volume capacity, and a mammalian production train with the ability to handle volumes of up to 2,000 liters. Northway Biotech has further established a specialized, fully automated fill and finish line to accommodate its clients' varied needs, supporting high-throughput filling into vials, syringes, and cartridges.
Prof. Vladas Algirdas Bumelis, CEO of Northway Biotech, shared his insights regarding this accomplishment, stating, "The addition of GMP suites in our US site represents a transformative step for our organization, enabling us to provide comprehensive end-to-end solutions from our second site now. We are poised to transition current process development projects into the cGMP manufacturing phase in a timely manner, in line with our clients' committed schedules. Additionally, our longstanding US partners who have engaged with our Lithuanian site can now also take advantage of the geographical convenience of our modern facilities located in the Greater Boston Area. With our fully functional and technologically advanced manufacturing site at our disposal, Northway Biotech is perfectly positioned to take on manufacturing projects aimed at both clinical and commercial supply."
To commemorate this significant expansion and express gratitude to its valued partners and industry leaders, Northway Biotech will be hosting a grand opening event for its cGMP suites on June 8. This event promises to be an occasion of celebration and networking, providing an opportunity for attendees to witness firsthand the state-of-the-art facilities and engage in meaningful discussions within the biotech community.
About Northway Biotech - https://www.northwaybiotech.com
Northway Biotech is a leading contract development and manufacturing organization (CDMO) supporting customers worldwide. Its highly experienced, professional team executes projects at any stage, from cell line construction and process development to cGMP manufacturing of biopharmaceutical products. The company's wide-ranging expertise and vertically integrated service offering translate to the ability to rapidly execute multiple projects from its state-of-the-art GMP facilities while ensuring full process and product compliance at all stages of research, development and commercial manufacturing. Northway Biotech is a privately-owned company founded in 2004 and located in Vilnius, Lithuania; London, United Kingdom; and Waltham, Massachusetts, United States.
For Further Information, Contact:
Prof. Vladas Algirdas Bumelis
CEO and Chairman of the Board
Northway Biotech
vladas.bumelis@northwaybiotech.com
Contact Information
Vladas Bumelis
CEO and Chairman of the Board
vladas.bumelis@northwaybiotech.com
SOURCE: Northway Biotech
To view this piece of content from stats.newswire.com, please give your consent at the top of this page.View source version on accesswire.com:
https://www.accesswire.com/757061/Northway-Biotech-Set-to-Launch-Advanced-Microbial-and-Mammalian-GMP-Facilities-in-Massachusetts
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Freedom Holding Corp. Founder Timur Turlov Announces Candidacy for FIDE Deputy President29.6.2026 15:25:00 CEST | Press release
ALMATY, KAZAKHSTAN AND NEW YORK, NY / ACCESS Newswire / June 29, 2026 / Timur Turlov, President of the Kazakhstan Chess Federation and founder and majority shareholder of Freedom Holding Corp., has announced his candidacy for the position of Deputy President of the International Chess Federation (FIDE). According to Turlov, his decision to run reflects the work the Kazakhstan Chess Federation has undertaken in recent years to develop, digitize and popularize chess across the country. "My goal is to bring more stability, balance and mutual understanding to FIDE. Freedom Holding Corp., as one of Central Asia's leading fintech groups, can help the federation become more digital and technology-driven," said Timur Turlov. He added that his candidacy also reflects Kazakhstan's growing role in the international chess community. "In this sense, I represent not only myself, but also Kazakhstan - a country that is increasingly seen internationally as a reliable partner, capable of building calm
Polaris Renewable Energy Announces Results of Director Elections at Annual and Special Meeting27.6.2026 01:40:00 CEST | Press release
TORONTO, ON / ACCESS Newswire / June 26, 2026 / Polaris Renewable Energy Inc. (TSX:PIF) ("Polaris" or the "Company"), is pleased to announce that all six director nominees proposed by management were elected as directors of the Company at its annual meeting of shareholders held via live video webcast today. Each director will hold office until the close of the next annual meeting of the Company's shareholders or until their successors are duly elected or appointed. The following are the voting results based on proxies received and a vote by online ballot: Director Number of Votes Percentage of Votes Votes For: Votes Withheld: Votes For: Votes Withheld: Jaime Guillen 9,351,125 220,821 97.69% 2.31% James V. Lawless 9,345,405 226,541 97.63% 2.37% Marc Murnaghan 9,355,472 216,474 97.74% 2.26% Marcela Paredes de Vásquez 9,383,074 188,872 98.03% 1.97% Catherine Fagnan 9,386,661 185,285 98.06% 1.94% Adarsh P. Mehta 9,394,433 177,513 98.15% 1.85% About Polaris Renewable Energy Inc. Polaris Ren
FINOS Announces Intent to Form OSERA, a Global Financial Services-Led Alliance for Open Source Supply-Chain Resiliency in the Era of AI26.6.2026 15:00:00 CEST | Press release
Spearheaded by Moderne and Piloted by FINOS Institutional Members, the Open Source Enterprise Resiliency Alliance Mutualizes Open Source 'Backpatching', Promotes Vendor-Neutral Industry-Wide Remediation Standards and Accelerates Evidence-Based, Compliant Open Source Consumption at Scale NEW YORK CITY, NY / ACCESS Newswire / June 26, 2026 / At the Open Source in Finance Forum, FINOS, the financial services arm of the Linux Foundation, announced its intent to form an Open Source Enterprise Resiliency Alliance (OSERA), a global, vendor-neutral, member-governed coalition to strengthen the industry's supply chain resiliency. OSERA will strengthen the open source components that underpin the sector by securing them through a vendor-neutral, upstream-aware approach and accelerating their compliant consumption at scale. The announcement follows a successful Member-only end-to-end pilot phase by Deutsche Bank, Goldman Sachs, Morgan Stanley, Royal Bank of Canada (RBC), and TD Bank Group, in whic
Hydrosat and Kazakhstan Gharysh Sapary Sign Agreement to Advance Satellite-Based Water Intelligence Across Kazakhstan and Central Asia25.6.2026 17:00:00 CEST | Press release
BRUSSELS, BE / ACCESS Newswire / June 25, 2026 / Hydrosat, the leading provider of thermal infrared satellite data and AI-powered analytics, and JSC "NC "Kazakhstan Gharysh Sapary" (JSC "NC "KGS"), Kazakhstan's national space company, announced the signing of a Joint Activity Agreement during a ceremony held in Brussels on 23 June 2026. The agreement establishes the framework for a national-scale program to digitize water resources management using satellite-based thermal analytics and AI, with the potential to expand across Central Asia. The agreement was signed as part of the state visit of the Head of State of the Republic of Kazakhstan to Belgium. During the visit, a number of strategic agreements were concluded to advance artificial intelligence, science, digital infrastructure, and space technologies, creating new opportunities for investment, joint research, technology deployment, and international cooperation. Representing Kazakhstan at the signing ceremonies were Deputy Prime
GA-ASI Adapts Ground Control Station to Fly MQ-9B25.6.2026 16:00:00 CEST | Press release
World Leader in UAS Invests in Upgrades That Ease MQ-9B Procurement SAN DIEGO, CA / ACCESS Newswire / June 25, 2026 / General Atomics Aeronautical Systems, Inc. (GA-ASI) is working to adapt its Block 30 Ground Control Stations (GCS) to fly the company's newer model MQ-9B SkyGuardian® and SeaGuardian® Remotely Piloted Aircraft. When these upgrades are complete, they will enable current users of the Block 30 system, originally designed to fly the MQ-9A Reaper®, to keep that equipment and use it to operate the more capable aircraft. Current users include the U.S. Air Force, U.S. Marine Corps, the Italian Air Force, the French Air Force, the United Arab Emirates Armed Forces, the Spanish Air Force, and the Royal Netherlands Air Force. GA-ASI developed the MQ-9B through its own internal research and development. The upgraded new aircraft required a new and more powerful GCS. The ongoing work with the Block 30 GCS now means that prospective users with existing stocks of equipment wouldn't ne
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom